US FDA clears Salix's mesalamine pills for ulcerative colitis

Salix Pharmaceuticals, Ltd. announced that the US Food and Drug Administration (FDA) has granted marketing approval for Apriso (mesalamine) extended-release capsules 0.375 g.

The details can be read here.